NCT04113694 - Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes | Biotech Hunter

Enrollment

291

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

November 5, 2020

Study Completion Date

November 5, 2020

Conditions

Diabetes

Interventions

DEVICE

Extended Infusion Set

Each subject is asked to wear each Extended Wear Infusion Set for at least 174 hours.

Trial Locations (15)

19053

Diabetes and Endocrinology Consultants of Pennsylvania, Feasterville-Trevose

22908

University of Virginia Health System, Charlottesville

30076

Endocrine Research Solutions, Roswell

30318

Atlanta Diabetes Associates, Atlanta

33401

Metabolic Research Institute, West Palm Beach

38133

AM Diabetes and Endocrinology Center, Memphis

48302

Grunberger Diabetes Institute, Bloomfield Hills

50265

Iowa Diabetes and Endocrinology Center, West Des Moines

55905

Mayo Clinic (Rochester MN), Rochester

72205

Medical Investigations, Little Rock

80045

Barbara Davis Center for Childhood Diabetes, Aurora

91790

SoCal Diabetes, West Covina

92025

AMCR Institute, Escondido

94304

Stanford University, Palo Alto

98057

Rainier Clinical Research Center, Renton

All Listed Sponsors

lead

Medtronic Diabetes

INDUSTRY